The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Zealand Pharma A/S briefly reclaimed its position as this year’s best performer in the Stoxx 600 Health Care Index on Friday, ...

SEC filing, will be determined "based on the book-building process" — but Medicus said it is expected to be close to the ...

BRS spokesperson Manne Krishank gave a strong counter to the claims of Medicover Hospitals that the hospital had no links ...

For Q2, the company’s revenue from the Indian market rose 13.9 per cent to Rs 1,281.7 crore, contributing 37 per cent to ...

Villagers have been fighting for justice for about nine months, yet neither the Chief Minister nor his officials had ...

Telangana attracts ₹36,000 crore investments in life sciences, becoming a global leader in pharmaceutical manufacturing and R ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

A ‘Unified Digital Pharmacy Platform’ (UDPP) could serve as a digital healthcare solution for senior citizens, eliminating ...

Source: Supplied. Industry experts, influencers, and pioneers from the world’s top pharmaceutical hubs will gather at the ...